Dr. Stephan von Haehling
LONDON – Cancer itself has cardiotoxic effects independent of those caused by chemotherapy, Dr. Stephan von Haehling... More
Dr. M. Catherine Pietanza
VIENNA – Rovalpituzumab tesirine, an antibody drug conjugate that targets delta-like protein 3, produced responses in a... More
Dr. James Yao
VIENNA – The mTOR inhibitor everolimus cut the risk of progression or death by 52% for patients with advanced,... More
Gov. Jerry Brown
California Gov. Jerry Brown (D) has signed into law a controversial measure that allows physicians to help terminally... More
Dr. Philippe Ruszniewski
VIENNA – After posting unprecedented results in the phase III NETTER-1 trial, the experimental radiopeptide therapy... More
Dr. Michael J. Silverberg
The cumulative rates of anal, colorectal, and liver cancers are increasing among HIV-positive patients, mainly because... More
GAO: Physicians, hospitals struggle to achieve EHR interoperability
Physicians and health care organizations are struggling to achieve interoperability, the exchange of data between their... More
FDA approves pembrolizumab for advanced NSCLC
The Food and Drug Administration has granted accelerated approval for pembrolizumab to treat patients with metastatic... More
Dr. John G. Gribben
CHICAGO – Consider using novel agents in chronic lymphocytic leukemia (CLL) patients who are refractory to treatment or... More
Chromosome 3 abnormalities linked to poor CML outcomes
Chromosome 3 abnormalities, specifically 3q26.2 rearrangements, were associated with treatment resistance and poor... More
FDA approves nivolumab-ipilimumab combination for melanoma
Nivolumab, a programmed death receptor-1 (PD-1)–blocking antibody, has been approved for use in combination with... More
Narrow-band colonoscopy faster, as sensitive as white light in ulcerative colitis
Among patients with ulcerative colitis (UC), narrow-band imaging colonoscopy with targeted and segmental biopsy... More
Dr. John G. Gribben
CHICAGO – The majority of patients with chronic lymphocytic leukemia (CLL) are elderly patients over age 65 years,... More
Dr. Ann Banke
LONDON – Adult patients with chronic heart failure had an average 51% increased incidence of all forms of cancer,... More
Dr. David Rimm
DENVER – In patients with non–small cell lung cancer (NSCLC), the programmed death-ligand 1 (PD-L1) status of the... More
Dr. Brittany L. Murphy
SAN FRANCISCO – Nipple-sparing mastectomy can be a safe surgical option for carefully selected patients with... More
SAN FRANCISCO – Nipple-sparing mastectomy can be a safe surgical option for carefully selected patients with node-positive breast cancers, investigators reported at the 2015 ASCO Breast Cancer Symposium. In a series of 226 patients with a total of... More »
SAN FRANCISCO – Breast density is an independent risk factor for positive lumpectomy margins, pointing to a need for better methods of intraoperative margin assessment, researchers contend. Data from a randomized clinical trial evaluating intraope... More »
Markers of impaired cardiovascular function are present in cancer patients even before they undergo cardiotoxic chemotherapy, suggesting the malignancy itself has cardiotoxic effects.... More »
VIENNA – Rovalpituzumab tesirine, an antibody drug conjugate that targets delta-like protein 3, produced responses in a range of patients with previously treated small-cell lung cancer in a phase I study. Responses to rovalpituzumab tesirine (Rova... More »
Almost 45% of physicians say that they have practiced defensive medicine, according to a survey of 1,001 physicians conducted by Physicians Practice, a practice management newspaper and website. To be exact, 44.6% of respondents said that they had o... More »
Levels of specific microRNAs (miRNAs) detected in the peripheral blood of patients with monoclonal gammopathy of undetermined significance (MGUS), and smoldering multiple myeloma may prove to predict progression to multiple myeloma, according to Weix... More »
Kartik Konduri et al
Lung cancer is the leading cause of cancer mortality in the United States, with more than 158,000 deaths from the disease expected in 2015. It accounts for 13% of new cancer diagnoses, yet contributes 27% of cancer deaths. With an overall 5-year surv... More »
While vulvar cancer is a rare gynecologic malignancy, it can be devastating for patients and families, especially at late stages. Early diagnosis and treatment is imperative for improved patient outcomes. An increased awareness among patients and phy... More »
With the race to develop cancer immunotherapies escalating and new agents appearing in the clinic, oncologists’ decision-making toolbox will need to evolve. “As immunotherapeutics become increasingly available to patients, clinicians face a majo... More »
S.Y. TAN, M.D.
Question: Which of the following statements regarding statutory caps on malpractice damages is best? A. All states have such a statutory provision. B. The provision limits the recovery of both economic and noneconomic losses. C. It’s constitutio... More »
Arefeh Davoodi et al
Background Gastrectomy affects different aspects of functionality and impacts on the quality of life (QoL) of patients with gastric cancer. The importance of appropriate assessment of QoL in cancer patients is well established, yet strategies that he... More »
Kathryn J Ruddy et al
Background Young women with breast cancer face different challenges than those faced by older women because of their age and life stage, yet few studies have focused on the different challenges faced by women from diverse populations. Objective To e... More »